Vertex Global HC Fund II Pte. Ltd. is 10% at Elevation Oncology, Inc. (ELEV). They have made 1 open-market trade across 1 company since 2021, most recently 2021-06-29.
CIK 0001868847
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELEV | 1,656,577 | $605K |
Shares reported on the most recent Form 4, priced at the 2021-06-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELEV | BUY | 2021-06-29 | 2021-06-29 | $16.00 | $4.0M | +25.8% | -36.8% | -35.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.